newsfilter
← Latest News
GlobeNewswire·

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

SILO
  • Silo Pharma, Inc. announced a private placement offering of 619,965 shares of common stock & associated Series A-3 & short-term Series A-4 warrants.
  • The purchase price for the shares & warrants is $6.452 per share.
  • The warrants carry an exercise price of $6.21 per share & are exercisable immediately upon issuance.
  • Series A-3 warrants will expire five years after the effective date of the Resale Registration Statement, while Series A-4 warrants will expire eighteen months after that date.
  • Aggregate gross proceeds from the offering are expected to be approximately $4 million before deducting fees & expenses.
  • Potential additional gross proceeds from the full cash exercise of all warrants are approximately $7.7 million.
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the transaction.
  • The offering is expected to close on or about July 10, 2026, subject to customary closing conditions.
  • The Company intends to use net proceeds for working capital & general corporate purposes.
  • Securities are being offered under Section 4(a)(2) of the Securities Act & Regulation D, with a registration rights agreement to file a Resale Registration Statement for future resale.